相关实验视频

Updated: Jan 9, 2026

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

从氧化捐赠者处选潜在药物用于治疗脱发,基于网络药理学和实验验证

Pan Guo^1,2, Mengke Sun¹, Hong Cui³

¹Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, China.

Chemical biology & drug design

|December 9, 2025

概括

氧化 (NO) 捐赠者通过影响毛囊细胞中的亡和衰老途径,显示出治疗脱发的潜力. 这项研究阐明了基于NO的头发生长疗法背后的分子机制.

科学领域:

皮肤病学和分子生物学
研究氧化在毛囊生物学和脱发症中的作用.
利用生物信息学来发现治疗脱发的治疗点.

背景情况:

氧化物 (NO) 历来与头发生长有关,但其确切的作用和NO捐赠者的疗效尚不清楚.
脱发症,包括雄激素脱发症 (AGA),脱发区 (AA) 和中心离心痕脱发症 (CCCA),在皮肤病治疗中构成了重大挑战.
了解NO对毛囊影响的分子基础对于开发新型治疗策略至关重要.

研究的目的:

系统地研究NO捐赠者的生理机制,用于治疗各种形式的脱发症.
确定关键的分子点和途径,参与NO介导的毛囊保护.
探索特定化合物的潜力,如hesperidin,减轻脱发.

主要方法:

使用DrugBank和SwissTargetPrediction数据库选七个NO捐赠者的化学标.
从GEO数据库中识别AGA,AA和CCCA的差异表达基因 (DEG).
执行综合生物信息学分析,以揭示潜在的治疗途径和目标.

主要成果:

对AGA (237),AA (266) 和CCCA (1158) 进行NO捐赠者和DEG的339个化学点.
通过将NO捐赠目标与CCCA DEG交叉,专注于20个CCCA相关的目标.
赫斯佩里丁 (HP) 通过与BCL2,MAPK8,MMP13和AURKB的相互作用,证明了对毛囊细胞中亡和衰老途径的双重调节作用.

结论:

阐明了NO捐赠体介导的毛囊保护的分子机制,特别是在CCCA中.
赫斯佩里丁通过调节关键细胞通路,有望缓解脱发.
这项研究为未来研究基于NO的脱发干预措施及其临床应用提供了基础.

关键词:

发症 (alopecia) 是一种脱发症.这就是hesperidin.我们的 iNOS iNOS 氧化氧化是一种氧化.氧化的捐赠者氧化的捐赠者

更多相关视频

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Published on: January 27, 2018

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

相关概念视频

Antihypertensive Drugs: Vasodilators

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Nitric Oxide Signaling Pathway

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...